SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fabrizio Stocchi, Ann Hsu, Sarita Khanna, Aaron Ellenbogen, Andreas Mahler, Grace Liang, Ulrich Dillmann, Robert Rubens, Sherron Kell, Suneel Gupta, Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients, Parkinsonism & Related Disorders, 2014,

    CrossRef

  2. 2
    Marina Senek, Dag Nyholm, Continuous Drug Delivery in Parkinson’s Disease, CNS Drugs, 2014, 28, 1, 19

    CrossRef

  3. 3
    Peter A. LeWitt, F. Jacob Huff, Robert A. Hauser, Dan Chen, Dmitri Lissin, Katie Zomorodi, Kenneth C. Cundy, Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease, Movement Disorders, 2014, 29, 1
  4. 4
    D. Nyholm, M. Ehrnebo, T. Lewander, C. G. Trolin, T. Bäckström, G. Panagiotidis, J. Spira, C. Nyström, S.-M. Aquilonius, Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers, Acta Neurologica Scandinavica, 2013, 127, 2
  5. 5
    Talene A Yacoubian, IPX066: a new intermediate- and extended-release carbidopa–levodopa formulation, Neurodegenerative Disease Management, 2013, 3, 2, 123

    CrossRef

  6. 6
    K. Ray Chaudhuri, Alexandra Rizos, Kapil D. Sethi, Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?, Journal of Neural Transmission, 2013, 120, 9, 1305

    CrossRef

  7. 7
    Ronald F. Pfeiffer, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  8. 8
    Ronald Pfeiffer, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  9. 9
    Robert A Hauser, IPX066: a novel carbidopa–levodopa extended-release formulation, Expert Review of Neurotherapeutics, 2012, 12, 2, 133

    CrossRef

  10. 10
    Robert A. Hauser, Aaron L. Ellenbogen, Leo Verhagen Metman, Ann Hsu, Martin J. O'Connell, Nishit B. Modi, Hsuan-Ming Yao, Sherron H. Kell, Suneel K. Gupta, Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease, Movement Disorders, 2011, 26, 12
  11. 11
    Angelo Antonini, K. Ray Chaudhuri, Pablo Martinez-Martin, Per Odin, Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease, CNS Drugs, 2010, 24, 2, 119

    CrossRef

  12. 12
    Seppo Kaakkola, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef